-
Mashup Score: 1JACC: CardioOncology: Vol 4, No 5 - 8 month(s) ago
Nathan E. Welty and Saar I. Gill J Am Coll Cardiol CardioOnc. 2022 Dec, 4 (5) 563–578. J Am Coll Cardiol CardioOnc. 2022 Dec, 4 (5) 579–597. Giselle Alexandra Suero-Abreu, Tomas G. Neilan, et. al. J Am Coll Cardiol CardioOnc. 2022 Dec, 4 (5) 598–615. J Am Coll Cardiol CardioOnc. 2022 Dec, 4 (5) 616–623. Franck Thuny, Jennifer Cautela, et. al. J Am Coll Cardiol Cardi oOnc. 2022 Dec, 4 (5) 624–628. J Am Coll Cardiol CardioOnc. 2022 Dec, 4 (5) 629–634. Megan Mulholland, Daniel Engelbertsen, et. al. J Am
Source: www.jacc.orgCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 0
Home > GI Cancer > Study Identifies Platelet-Derived circRNAs as Biomarkers in Patients With GEP-NETs For the first time, researchers identified a circular RNA (circRNA) signature from tumor-educated platelets (TEPs) as a potential diagnostic and predictive biomarker for gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Their findings were published in the Journal of Translational Medicine. According to researchers, early diagnosis of NETs “is a clinical challenge that requires a deep understanding
Source: www.docwirenews.comCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 0Future research with advanced imaging technology and biomarkers - 9 month(s) ago
The identification of cardiovascular (CV) diseases before their clinical manifestation is supposed to be a very useful tool to better stratify and manage the CV
Source: academic.oup.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0
Get Beyond Health has created a tech platform to provide personalised health card where users can get relevant answers for any query.
Source: YourStory.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 1
Pathological LN regression after neoadjuvant chemotherapy was a strong prognostic factor and provides important information beyond pathological TNM staging and primary tumor regression grading. LN regression should be included as standard in the pathological reporting of esophagectomy specimens.
Source: pubmed.ncbi.nlm.nih.govCategories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 4ESMO E-Learning and V-Learning | OncologyPRO - 9 month(s) ago
ESMO E-Learning: Prognostic and Predictive Biomarkers in Head and Neck Cancer
Source: oncologypro.esmo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0NIH awards will fund Post-Treatment Lyme Disease Syndrome research - 10 month(s) ago
Between 10 and 20% of people infected with Lyme disease experience PTLDS.
Source: www.nih.govCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
Starting in January 2025, health plans must cover biomarker tests, thanks to a change at the Minnesota State Capitol this year.
Source: www.cbsnews.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Biopsy and blood-based molecular biomarker of inflammation in IBD - 10 month(s) ago
Objective IBD therapies and treatments are evolving to deeper levels of remission. Molecular measures of disease may augment current endpoints including the potential for less invasive assessments. Design Transcriptome analysis on 712 endoscopically defined inflamed (Inf) and 1778 non-inflamed (Non-Inf) intestinal biopsies (n=498 Crohn’s disease, n=421 UC and 243 controls) in the Mount Sinai…
Source: GutCategories: Gastroenterology, Latest HeadlinesTweet
-
Mashup Score: 2ISHLT: The International Society for Heart & Lung Transplantation - Research Grants - 10 month(s) ago
Accept Cookies & Privacy Policy? This website uses cookies to ensure the best possible web experience. By continuing and using the site, you consent to the use of cookies. If you wish to disable them or to learn more about how we use cookies, please view our Cookies Policy. …
Source: ishlt.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet
Enjoying the #ESCCongress session on emerging #biomarkers in cardiology happening now? Check out our related #JACCCardioOnc special issue for more resources: https://t.co/M6Akr6o0W0 #CardioTwitter #CardioOnc #ImmuneTherapy https://t.co/yICtTf2Uek